Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 6
2005 8
2006 3
2007 7
2008 11
2009 7
2010 8
2011 12
2012 7
2013 8
2014 6
2015 3
2016 3
2017 3
2018 5
2019 6
2020 5
2021 10
2022 15
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
Wheeler DC, Stefansson BV, Batiushin M, Bilchenko O, Cherney DZI, Chertow GM, Douthat W, Dwyer JP, Escudero E, Pecoits-Filho R, Furuland H, Górriz JL, Greene T, Haller H, Hou FF, Kang SW, Isidto R, Khullar D, Mark PB, McMurray JJV, Kashihara N, Nowicki M, Persson F, Correa-Rotter R, Rossing P, Toto RD, Umanath K, Van Bui P, Wittmann I, Lindberg M, Sjöström CD, Langkilde AM, Heerspink HJL. Wheeler DC, et al. Among authors: wittmann i. Nephrol Dial Transplant. 2020 Oct 1;35(10):1700-1711. doi: 10.1093/ndt/gfaa234. Nephrol Dial Transplant. 2020. PMID: 32862232 Free PMC article. Clinical Trial.
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.
Wheeler DC, Jongs N, Stefansson BV, Chertow GM, Greene T, Hou FF, Langkilde AM, McMurray JJV, Rossing P, Nowicki M, Wittmann I, Correa-Rotter R, Sjöström CD, Toto RD, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Wheeler DC, et al. Among authors: wittmann i. Nephrol Dial Transplant. 2022 Aug 22;37(9):1647-1656. doi: 10.1093/ndt/gfab335. Nephrol Dial Transplant. 2022. PMID: 34850160 Free PMC article. Clinical Trial.
[Cardiorenal syndromes].
Késöi I, Sági B, Vas T, Pintér T, Kovács T, Wittmann I, Nagy J. Késöi I, et al. Among authors: wittmann i. Orv Hetil. 2011 Sep 18;152(38):1520-7. doi: 10.1556/OH.2011.29212. Orv Hetil. 2011. PMID: 21896443 Review. Hungarian.
[Diabetology and solid organ transplantation].
Wagner L, Wittmann I, Piros L, P Szabó R, Szakály P. Wagner L, et al. Among authors: wittmann i. Orv Hetil. 2018 Nov;159(46):1930-1939. doi: 10.1556/650.2018.31281. Orv Hetil. 2018. PMID: 30450927 Review. Hungarian.
[Secondary IgA-nephropathy in gastroenterological diseases].
Szigeti N, Kovács T, Degrell P, Fábián G, Wittmann I, Nagy J. Szigeti N, et al. Among authors: wittmann i. Orv Hetil. 2007 Feb 18;148(7):313-8. doi: 10.1556/OH.2007.27984. Orv Hetil. 2007. PMID: 17344151 Review. Hungarian.
[Nephrogenic systemic fibrosis].
Pintér I, Vágási K, Wittmann I, Nagy J. Pintér I, et al. Among authors: wittmann i. Orv Hetil. 2007 Sep 23;148(38):1801-4. doi: 10.1556/OH.2007.28183. Orv Hetil. 2007. PMID: 17872335 Review. Hungarian.
130 results